Breast 1

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

Adjuvant

treatment

Post operative
PREDICT/Nottingham
Prognostic Index

Will adjuvant
therapy potentially
help

Highly Advantagous Poorly Advantageous

Oncotype DX Adjuvant Endocrine

ER+ HER2+
Oncotype DX
suggests chemotherapy useful.
Tumour >0.5cm
Trastuzumab &
Pertuzumab
Yes No with concurrent
Chemotherapy
(2-4 months)
Adjuvant No Adjuvant
Chemotherapy Chemotherapy

12 m total
Trastuzumab

Age Pre-menopausal Post Menopausal

Exemestane &
<35 >40 Tamoxifen
Ovarian Suppression

Aromatase inhibitors
High risk features Low risk featurea (Letrozole/ Anastrozole)
10 years 5 years

You might also like